Amphiregulin mediates progesterone-induced mammary ductal development during puberty

Breast Cancer Research

Volumn 15, Issue 3, 2013, Pages

  Aupperlee, Mark D ^a   Leipprandt, Jeffrey R ^a   Bennett, Jessica M ^a   Schwartz, Richard C ^b   Haslam, Sandra Z ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; SODIUM CHLORIDE; ESTROGEN; TNFSF11 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CANCER RISK; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; MAMMARY END BUD; MAMMARY GLAND; MOUSE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; PUBERTY; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; RISK FACTOR; UDDER;

AMPHIREGULIN; ANIMALS; CELL PROLIFERATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; OVARIECTOMY; PROGESTERONE; PUBERTY; RANK LIGAND; RISK FACTORS;

EID: 84878004848     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3431     Document Type: Article

References (46)

1. Fenton SE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 2006, 147(6 Suppl):S18-24.
2. Kariagina A, Aupperlee MD, Haslam SZ. Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Exp 2008, 18:11-33.
3. Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer 2008, 8:334-342. 10.3816/CBC.2008.n.038, 2666469, 18757260.
4. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 1978, 61:1439-1449.
5. Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996, 39:7-20. 10.1007/BF01806074, 8738602.
6. Haslam SZ. Age as a modifying factor of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the Lewis rat. Int J Cancer 1979, 23:374-379. 10.1002/ijc.2910230316, 108227.
7. Haslam SZ. The effect of age on the histopathogenesis of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in the Lewis rat. Int J Cancer 1980, 26:349-356. 10.1002/ijc.2910260315, 6793523.
8. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J. Hormone dependence in premalignant mammary progression. Cancer Res 2003, 63:1067-1072.
9. Howlin J, McBryan J, Martin F. Pubertal mammary gland development: insights from mouse models. J Mammary Gland Biol Neoplasia 2006, 11:283-297. 10.1007/s10911-006-9024-2, 17089203.
10. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278. 10.1101/gad.9.18.2266, 7557380.
11. Shi HY, Lydon JP, Zhang M. Hormonal defect in maspin heterozygous mice reveals a role of progesterone in pubertal ductal development. Mol Endocrinol 2004, 18:2196-2207. 10.1210/me.2004-0052, 15178746.
12. Ruan W, Monaco ME, Kleinberg DL. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 2005, 146:1170-1178.
13. Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, Vonderhaar BK. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol 2000, 167:39-52. 10.1677/joe.0.1670039, 11018751.
14. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 2001, 222:192-205. 10.1002/dvdy.1179, 11668597.
15. Satoh K, Hovey RC, Malewski T, Warri A, Goldhar AS, Ginsburg E, Saito K, Lydon JP, Vonderhaar BK. Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene 2007, 26:7526-7534. 10.1038/sj.onc.1210555, 17546050.
16. Ohi Y, Yoshida H. Influence of estrogen and progesterone on the induction of mammary carcinomas by 7,12-dimethylbenz(a)anthracene in ovariectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol 1992, 62:365-370. 10.1007/BF02899705, 1360723.
17. Daniel CW, Silberstein GB, Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987, 47:6052-6057.
18. Aupperlee MD, Haslam SZ. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 2007, 148:2290-2300. 10.1210/en.2006-1721, 17317767.
19. Ciarloni L, Mallepell S, Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA 2007, 104:5455-5460. 10.1073/pnas.0611647104, 1838509, 17369357.
20. Banerjee MR, Wood BG, Lin FK, Crump LR. Organ culture of whole mammary gland of the mouse. Tissue Culture Assoc Man 1976, 2:457-462.
21. Aupperlee MD, Smith KT, Kariagina A, Haslam SZ. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 2005, 146:3577-3588. 10.1210/en.2005-0346, 15878961.
22. Haslam SZ, Drolet A, Smith K, Tan M, Aupperlee M. Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture. Endocrinology 2008, 149:2098-2107. 10.1210/en.2007-1398, 2329279, 18218689.
23. Fendrick JL, Raafat AM, Haslam SZ. Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse. J Mammary Gland Biol Neoplasia 1998, 3:7-22. 10.1023/A:1018766000275, 10819501.
24. Aupperlee MD, Drolet AA, Durairaj S, Wang W, Schwartz RC, Haslam SZ. Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology 2009, 150:1485-1494. 2654739, 18988671.
25. Zeps N, Bentel JM, Papadimitriou JM, Dawkins HJ. Murine progesterone receptor expression in proliferating mammary epithelial cells during normal pubertal development and adult estrous cycle: association with ERalpha and ERbeta status. J Histochem Cytochem 1999, 47:1323-1330. 10.1177/002215549904701012, 10490461.
26. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development (Cambridge, England) 1999, 126:2739-2750.
27. Fernandez-Valdivia R, Mukherjee A, Creighton CJ, Buser AC, DeMayo FJ, Edwards DP, Lydon JP. Transcriptional response of the murine mammary gland to acute progesterone exposure. Endocrinology 2008, 149:6236-6250. 10.1210/en.2008-0768, 2613059, 18687774.
28. Das SK, Chakraborty I, Paria BC, Wang XN, Plowman G, Dey SK. Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol Endocrinol 1995, 9:691-705. 10.1210/me.9.6.691, 8592515.
29. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 2003, 100:9744-9749. 10.1073/pnas.1732707100, 187836, 12897242.
30. Schroeder JA, Lee DC. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 1998, 9:451-464.
31. Sternlicht MD, Sunnarborg SW. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia 2008, 13:181-194. 10.1007/s10911-008-9084-6, 2723838, 18470483.
32. Eccles SA. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. Int J Dev Biol 2011, 55:685-696. 10.1387/ijdb.113396se, 22161825.
33. Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 2006, 103:2196-2201. 10.1073/pnas.0510974103, 1413744, 16452162.
34. McBryan J, Howlin J, Napoletano S, Martin F. Amphiregulin: role in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2008, 13:159-169. 10.1007/s10911-008-9075-7, 18398673.
35. Wiesen JF, Young P, Werb Z, Cunha GR. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development (Cambridge, England) 1999, 126:335-344.
36. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, Choi Y, Schneider P, Brisken C. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci USA 2010, 107:2989-2994. 10.1073/pnas.0915148107, 2840294, 20133621.
37. Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 2010, 316:422-432. 10.1016/j.yexcr.2009.11.006, 2812656, 19913532.
38. Booth BW, Smith GH. Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res 2006, 8:R49. 10.1186/bcr1538, 1779481, 16882347.
39. Pelekanou V, Leclercq G. Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis. Int J Dev Biol 2011, 55:869-878. 10.1387/ijdb.113369vp, 22161842.
40. Zhao Y, Tan YS, Haslam SZ, Yang C. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. Toxicol Sci 2010, 115:214-224. 10.1093/toxsci/kfq030, 2855353, 20118188.
41. Kariagina A, Xie J, Leipprandt JR, Haslam SZ. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers. Hormones Cancer 2010, 1:229-244. 10.1007/s12672-010-0048-0, 3000471, 21258428.
42. Johnston SR. Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer. Clin Cancer Res 2006, 12(3 Pt 2):1061s-1068s.
43. LaMarca HL, Rosen JM. Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res 2007, 9:304. 10.1186/bcr1740, 2206713, 17659070.
44. Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997, 57:4987-4991.
45. Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM. C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 2000, 14:359-368. 10.1210/me.14.3.359, 10707954.
46. Russo J, Ao X, Grill C, Russo IH. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999, 53:217-227. 10.1023/A:1006186719322, 10369068.